Avenue Biosciences: Funding, Investors & Team (Oct 2026)
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biologics and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit.
Avenue Biosciences has raised $9.9M across 2 funding rounds on record, the most recent a Seed of $7.4M announced in Jan 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avenue Biosciences Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Avenue Biosciences Funding Rounds
Avenue Biosciences raised $2.5M in a Seed announced in Oct 2024.
1.3 years later, a Seed of $7.4M was announced in Jan 2026.
Avenue Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Avenue Biosciences Funding Compared to Other Biotechnology Startups
Avenue Biosciences' latest round of $7.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avenue Biosciences in Biotechnology and Palo Alto
Companies Similar to Avenue Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Avenue Biosciences Funding FAQs
What does Avenue Biosciences do?
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biologics and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit.
How much funding has Avenue Biosciences raised?
Avenue Biosciences has raised $9.9M across 2 rounds on record. The most recent is a Seed of $7.4M announced in Jan 2026.
When did Avenue Biosciences last raise funding?
Avenue Biosciences' most recent funding round on record is a Seed of $7.4M, announced in Jan 2026.
Who founded Avenue Biosciences?
FundedIQ lists Katja Rosti (Founder), Tero Pekka Alastalo (Founder) at Avenue Biosciences.
Where is Avenue Biosciences headquartered?
Avenue Biosciences is based in Palo Alto, California, United States.
How many employees does Avenue Biosciences have?
Avenue Biosciences is in the 11-50 employee band.
How does Avenue Biosciences' funding compare to other Biotechnology startups?
Avenue Biosciences' latest round of $7.4M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Avenue Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avenue Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.